The company is looking to target both oncology and non-oncology targets and boasts 10 different programs in its pipeline with combination therapies and monotherapies. The company still has a small team in the US, however, with the planned growth over the next 12 months it proves to be a company with great ambition and opportunity for growth for the people joining now.
What is required from an applicant is 3+ years experience of in monitoring of clinical trials in pharma, biotech, or CRO setting and having a good understanding of the workings of running a clinical trial from a site perspective.
If less travel and a move into a biotech sounds like something you could be interested in, then please get in touch.
